Cargando…
Checkpoint kinase-1 inhibition and etoposide exhibit a strong synergistic anticancer effect on chronic myeloid leukemia cell line K562 by impairing homologous recombination DNA damage repair
Leukemia, a malignant hematological disease, has poor therapeutic outcomes due to chemotherapeutic resistance. Increasing evidence has confirmed that the elevated capacity for DNA damage repair in cancer cells is a major mechanism of acquired chemotherapeutic resistance. Thus, combining chemotherapy...
Autores principales: | Fan, Zhuoyi, Luo, Huacheng, Zhou, Jie, Wang, Fangce, Zhang, Wenjun, Wang, Jian, Li, Shuo, Lai, Qian, Xu, Yueshuang, Wang, Guangming, Liang, Aibin, Xu, Jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7551253/ https://www.ncbi.nlm.nih.gov/pubmed/32901871 http://dx.doi.org/10.3892/or.2020.7757 |
Ejemplares similares
-
A three-lncRNA signature for prognosis prediction of acute myeloid leukemia in patients
por: Wang, Fangce, et al.
Publicado: (2018) -
Integrated transcriptomic and epigenetic data analysis identifiesaberrant expression of genes in acute myeloid leukemia with MLL-AF9 translocation
por: Wang, Fangce, et al.
Publicado: (2020) -
Integrated transcriptomic and epigenetic data analysis identifies aberrant expression of genes in acute myeloid leukemia with MLL-AF9 translocation
por: Wang, Fangce, et al.
Publicado: (2021) -
SIRT1 regulates the phosphorylation and degradation of P27 by deacetylating CDK2 to promote T-cell acute lymphoblastic leukemia progression
por: Wang, Fangce, et al.
Publicado: (2021) -
Characterization of an Etoposide‐resistant Human K562 Cell Line, K/eto
por: Sugawara, Isamu, et al.
Publicado: (1991)